Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Jorge Saucedo to Coronary Artery Disease

This is a "connection" page, showing publications Jorge Saucedo has written about Coronary Artery Disease.

 
Connection Strength
  
 
 
2.045
  
  1. Dasari TW, Cohen DJ, Kleiman NS, Keyes MJ, Yen CH, Hanna EB, Saucedo JF. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry). Am J Cardiol. 2014 Feb 15; 113(4):621-5.
    View in: PubMed
    Score: 0.316
  2. Hanna EB, Chen AY, Roe MT, Saucedo JF. Characteristics and in-hospital outcomes of patients presenting with non-ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: stratification according to renal function. Am Heart J. 2012 Jul; 164(1):52-7.e1.
    View in: PubMed
    Score: 0.286
  3. Dasari TW, Hennebry TA, Hanna EB, Saucedo JF. Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature. Catheter Cardiovasc Interv. 2011 Jun 01; 77(7):962-9.
    View in: PubMed
    Score: 0.262
  4. Hanna EB, Rao SV, Manoukian SV, Saucedo JF. The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes. JACC Cardiovasc Interv. 2010 Dec; 3(12):1209-19.
    View in: PubMed
    Score: 0.257
  5. Saucedo JF, Garza L, Wolford DC, Cook SL, Ramanathan KB, Matin Z, McGrew FA, Jacoski MV, Jennings LK. Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study). Am J Cardiol. 2004 May 15; 93(10):1279-82.
    View in: PubMed
    Score: 0.163
  6. Hennebry TA, Saucedo JF. "No-option" patients: a nightmare today, a future with hope. J Interv Cardiol. 2004 Apr; 17(2):93-4.
    View in: PubMed
    Score: 0.162
  7. Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, Alfonso F, Latib A, Ong PJ, Rissanen TT, Saucedo J, Scheller B, Kleber FX. Drug-Coated Balloons for Coronary?Artery Disease: Third Report of the International?DCB?Consensus Group. JACC Cardiovasc Interv. 2020 06 22; 13(12):1391-1402.
    View in: PubMed
    Score: 0.124
  8. Quadri G, D'Ascenzo F, Moretti C, D'Amico M, Raposeiras-Roub?n S, Abu-Assi E, Henriques JPS, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Omed? P, Montefusco A, Giordana F, Scarano S, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Varbella F, Gaita F. Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry. EuroIntervention. 2017 Jul 20; 13(4):407-414.
    View in: PubMed
    Score: 0.102
  9. Dasari TW, Saucedo JF, Krim S, Alkhouli M, Fonarow GC, Alvarez R, Ibrahim H, Dai D, Wang TY, Costa M, Lindenfeld J, Messenger JC. Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry. Am Heart J. 2015 Dec; 170(6):1086-91.
    View in: PubMed
    Score: 0.090
  10. Braun O?, Angiolillo DJ, Ferreiro JL, Jakubowski JA, Winters KJ, Effron MB, Duvvuru S, Costigan TM, Sundseth S, Walker JR, Saucedo JF, Kleiman NS, Varenhorst C. Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways. Thromb Haemost. 2013 Dec; 110(6):1223-31.
    View in: PubMed
    Score: 0.078
  11. Angiolillo DJ, Badimon JJ, Saucedo JF, Frelinger AL, Michelson AD, Jakubowski JA, Zhu B, Ojeh CK, Baker BA, Effron MB. A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. Eur Heart J. 2011 Apr; 32(7):838-46.
    View in: PubMed
    Score: 0.065
  12. Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV, Brindis RG, Gibson CM, Kleiman NS, Saucedo JF, Bhatt DL, Gibler WB, Ohman EM, Harrington RA, Roe MT. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J. 2006 Oct; 152(4):641-7.
    View in: PubMed
    Score: 0.048
  13. Labinaz M, Madan M, O'Shea JO, Kilaru R, Chin W, Pieper K, McGuire DK, Saucedo JF, Talley JD, Lui H, Kitt MM, Califf RM, Tcheng JT. Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial). Am J Cardiol. 2002 Sep 15; 90(6):585-90.
    View in: PubMed
    Score: 0.036
  14. Lansky AJ, Popma JJ, Mintz GS, Laird JR, Saucedo JF, Leon MB. Lipid-lowering therapy after coronary revascularization: the interventional cardiologist's perspective. Am J Cardiol. 1998 Apr 09; 81(7A):55E-62E.
    View in: PubMed
    Score: 0.027
  15. Yeo KK, Li S, Amsterdam EA, Wang TY, Bhatt DL, Saucedo JF, Kontos MC, Roe MT, French WJ. Comparison of clinical characteristics, treatments and outcomes of patients with ST-elevation acute myocardial infarction with versus without new or presumed new left bundle branch block (from NCDR?). Am J Cardiol. 2012 Feb 15; 109(4):497-501.
    View in: PubMed
    Score: 0.017
  16. Latif F, Kleiman NS, Cohen DJ, Pencina MJ, Yen CH, Cutlip DE, Moliterno DJ, Nassif D, Lopez JJ, Saucedo JF. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Jan; 2(1):37-45.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.